Endnotes
CHAPTER 1. FOUNDATIONS OF OXIDATIVE THERAPIES
1. R. Radel and M. H. Navidi, Chemistry (St. Paul, Minn.: West Publishing, 1990), 441, 445.
2. S. S. Hendler, The Oxygen Breakthrough (New York: Pocket Books, 1989), 79.
3. M. Barry and M. Cullen, “The Air You Breathe Up There,” Conde Nast Traveler (December 1993): 110–12.
4. Otto Warburg, The Prime Cause and Prevention of Cancer (Wurzburg, Germany: K. Triltsch, 1966).
5. D. M. Considine, ed., Van Nostrand’s Scientific Encyclopedia, 7th ed., vol. 2 (New York: Van Nostrand Reinhold, 1989), 2112.
6. Natalie Angier, “The Price We Pay for Breathing,” New York Times Magazine (April 25, 1993): 64.
7. David Lin, Free Radicals and Disease Prevention (New Canaan, Conn.: Keats Publishing, 1993), 19–21.
8. Sara Shannon, Good Health in a Toxic World: The Complete Guide to Fighting Free Radicals (New York: Warner Books, 1994).
9. Stephen A. Levine and Parris Kidd, Antioxidant Adaptation (San Leandro, Calif.: Allergy Research Group, 1986), 63.
10. Natalie Angier, “The Price We Pay for Breathing,” New York Times Magazine (April 25, 1993): 100.
CHAPTER 2. WHAT ARE OXIDATIVE THERAPIES?
1. Velio Bocci, Ozone: A New Medical Drug (Dordrecht, Netherlands: Springer, 2005), 28.
2. Ibid., 22–24, 27.
3. Marie Theres Jacobs, “Adverse Effects and Typical Complications in Ozone-Oxygen Therapy,” Ozonachrichten 1982, no. 1: 193–201.
4. I. N. Love, “Peroxide of Hydrogen as a Remedial Agent,” Journal of the American Medical Association (March 3, 1888): 262–65.
5. Oxidative Therapy (Oklahoma City, Okla.: IBOM, n.d.), 2–3.
6. International Scientific Committee of Ozone Therapy, Madrid Declaration on Ozone Therapy, 2nd ed. (Madrid: International Scientific Committee of Ozone Therapy, 2015): 29–31.
7. Frank Shallenberger, “Intravenous Ozone Therapy in HIV Related Disease,” in Proceedings of the 4th International Bio-Oxidative Medicine Conference (Oklahoma City, Okla.: IBOM, 1993).
8. Robert Atkins, interview in Ozone and the Politics of Medicine (Vancouver: Threshold Film, 1993).
9. Michael T. F. Carpendale, interview in Ozone and the Politics of Medicine (Vancouver: Threshold Film, 1993).
10. Horst Kief, interview in Ozone and the Politics of Medicine (Vancouver: Threshold Film, 1993).
11. “Drug’s Lucrative Sales, Some Danger Signals and Role of the F.D.A.,” New York Times (June 10, 2005): A1, C6.
12. The Value Line Investment Survey (October 9, 2015), 1605–34.
13. Visit www.opensecrets.org (accessed November 2, 2015). Search for the term “pharmaceuticals/health products” for more articles on this topic.
14. See Journal of the American Medical Association 314, no. 15 (October 20, 2015).
15. See Family Circle, November 2015.
16. B. R. Cassileth, “Oxygen Therapies,” Oncology 23, no. 13 (November 30, 2009): 1132, www.cancernetwork.com/oncology-journal/oxygen-therapies#sthash.KhyPOCEa.dpuf (accessed December 20, 2015).
17. National Institute on Drug Abuse,“Drug Facts: Heroin,” revised October 2014, www.drugabuse.gov/publications/drugfacts/heroin (accessed December 20, 2015).
18. Center for Disease Control and Prevention, “Injury Prevention & Control: Prescription Drug Overdoses,” November 4, 2015, www.cdc.gov/drugoverdose/data/overdose.html (accessed December 5, 2015).
19. National Institute on Drug Abuse, “America’s Addiction to Opioids: Heroin and Prescription Drug Abuse,” presented by Nora D. Volkow, M.D., Senate Caucus on International Narcotics Control, May 14, 2014, www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2015/americas-addiction-to-opioids-heroin-prescription-drug-abuse#_ftn2 (accessed December 20, 2015).
20. Agency for Healthcare Research and Quality (Rockville, Maryland), “Ending Health Care-Associated Infections,” October 2014, www.ahrq.gov/research/findings/factsheets/errors-safety/haicusp/index.html (accessed December 20, 2015).
21. Agency for Healthcare Research and Quality (Rockville, Maryland), “Saving Lives and Saving Money: Hospital-Acquired Conditions Update,” December 2015, www.ahrq.gov/professionals/quality-patient-safety/pfp/interimhacrate2014.html (accessed December 20, 2015), and “Appendix: Incidence of Hospital-Acquired Conditions in the Partnership for Patients: Estimates and Projected and Measured Impact,” November 2015, www.ahrq.gov/professionals/quality-patient-safety/pfp/interimhac2014-ap1.html (accessed December 20, 2015).
CHAPTER 3. OZONE: PROPERTIES AND USES
1. Chemical Technology: An Encyclopedic Treatment, vol. 1 (New York: Barnes & Noble, 1968), 79.
2. Bernard M. Babior et al., “Investigating Antibody-Catalyzed Ozone Generation by Human Neutrophils,” Proceedings of the National Academy of Sciences USA 100, no. 6 (March 18, 2003): 3031–34.
3. Renate Viebahn-Haensler, The Use of Ozone in Medicine, 4th English ed. (Iffezheim, Germany: ODREI-Publishers, 2002), 19.
4. Chemical Technology: An Encyclopedic Treatment, vol. 1 (New York: Barnes & Noble, 1968), 82–83.
5. McGraw-Hill Encyclopedia of Science & Technology, vol. 12, 6th ed. (New York: McGraw-Hill, 1987), 610.
6. Kirk Othmer, The Encyclopedia of Chemical Technology, vol. 16, 3rd ed. (New York: John Wiley & Sons, 1981), 705.
7. Ibid., 704.
8. Renate Viebahn-Haensler, The Use of Ozone in Medicine, 4th English ed. (Iffezheim, Germany: ODREI-Publishers, 2002), 18.
9. Ibid., 19–20.
10. James Dulley, “The Sensible Home: Ozone Is a Solid Pool, Spa Purifier,” Los Angeles Times (May 12, 1996): 5.
11. Chemical Technology: An Encyclopedic Treatment, vol. 1 (New York: Barnes & Noble, 1968), 82.
12. Kirk Othmer, The Encyclopedia of Chemical Technology, vol. 16, 3rd ed. (New York: John Wiley & Sons, 1981), 710.
13. Ibid.; Chemical Technology: An Encyclopedic Treatment, vol. 1 (New York: Barnes & Noble, 1968), 82.
14. L. R. Beuchat, “Surface Disinfection of Raw Produce,” Dairy, Food and Environmental Sanitation 12, no. 1 (1992): 6–9.
15. Liangji Xu, “Use of Ozone to Improve the Safety of Fresh Fruits and Vegetables,” Food Technology (October 1999): 58–62.
16. M. M. Barth et al., “Ozone Storage Effects on Anthocyanin Content and Fungal Growth in Blackberries,” Journal of Food Science 60, no. 6 (November 1995): 1286–88.
17. M. A. Khadre et al., “Microbiological Aspects of Ozone Applications in Food: A Review,” Journal of Food Science 66, no. 9 (November 2001): 1242–52.
18. A. D. Prudente Jr. and J. M. King, “Efficacy and Safety Evaluation of Ozonation to Degrade Aflatoxin in Corn,” Journal of Food Science 67, no. 8 (October 2002): 2866–72.
19. M. Balawejder et al., “Potential of Ozone Utilization for Reduction of Pesticide Residue in Food of Plant Origin: A Review,” Roczniki Państwowego Zakładu Higieny 64, no. 1 (2013): 13–18.
20. Paul Eng, “Potato Technology May Protect Mail From Anthrax, ABC News, http://abcnews.go.com/Technology/CuttingEdge/story?id=98108&page=1 (accessed March 22, 2017).
21. Will Knight, “Ozone Tested as Anti-Anthrax Weapon,” New Scientist (January 28, 2002): 44.
22. “OzoneSterilization,” Self Study Series Lesson No. 83 (July 2005). Continuing Education Division, Purdue University.
CHAPTER 4. OZONE IN MEDICINE
1. S. R. Beckwith, A New Therapeutics for the Cure of Disease by Sending Ozone, Oxygen and Medicine into Diseased Tissues (New York: Thermo-Ozone Company, 1899).
2. Renate Viebahn-Haensler, The Use of Ozone in Medicine, 4th English ed. (Iffezheim, Germany: ODREI-Publishers, 2002), 24–25.
3. Paul Wentworth et al., “Evidence for Antibody-Catalyzed Ozone Formation in Bacterial Killing and Inflammation,” Science (December 13, 2002): 2195–99.
4. Jean Marx, “Antibodies Kill by Producing Ozone,” Science (November 15, 2002): 1319.
5. A. C. Baggs, “Are Worry-Free Transfusions Just a Whiff of Ozone Away?” Canadian Medical Association Journal (April 1, 1993): 1159.
6. Margaret Gilpin, “Update-Cuba: On the Road to a Family Medicine Nation,” Journal of Public Health Policy 12, no. 1 (Spring 1991): 90–91.
7. Andres Oppenheimer, Castro’s Final Hour (New York: Touchstone Books, 1993), 82–83.
8. V. Bocci and L. Paulesu, “Studies on the Biological Effects of Ozone 1: Induction of Interferon Gamma on Human Leucocytes,” Haematologica 75 (1990): 510–15.
9. Renate Viebahn-Haensler, The Use of Ozone in Medicine, 4th English ed. (Iffezheim, Germany: ODREI-Publishers, 2002), 27.
10. Ibid., 42–47.
11. Ibid.; Proceedings of the First Iberolatinamerican Congress on Ozone Application (Havana, Cuba: National Center for Scientific Research, 1990); Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989); Silvia Menendez, Ozomed/Ozone Therapy (Havana, Cuba: National Center for Scientific Research, 1993).
CHAPTER 5. HOW IS OZONE THERAPY APPLIED?
1. Renate Viebahn-Haensler, The Use of Ozone in Medicine, 4th English ed. (Iffezheim, Germany: ODREI-Publishers, 2002), 44–47.
2. Gerard Sunnen, “Ozone in Medicine: Overview and Future Direction,” Journal of Advancement in Medicine 1, no. 3 (Fall 1988).
3. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 213–14.
4. Renate Viebahn-Haensler, The Use of Ozone in Medicine, 4th English ed. (Iffezheim, Germany: ODREI-Publishers, 2002), 45.
5. Horst Kief, Therapeutic Significance of Intestinal Insufflation of Medical Ozone (Ludwigshafen, Germany: Kief Clinic, n.d.).
6. Silvia Menéndez et al., Ozono: Aspectos básicos y aplicaciones clínicas (Havana: Centro de Investigaciones del Ozono, 2008), 129.
7. Ibid.
8. Renate Viebahn-Haensler, The Use of Ozone in Medicine, 4th English ed. (Iffezheim, Germany: ODREI-Publishers, 2002), 44.
9. Ibid.
10. Gerard Sunnen, “Ozone in Medicine: Overview and Future Direction,” Journal of Advancement in Medicine 1, no. 3 (Fall 1988).
11. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 211–12.
12. Ed McCabe, Flood Your Body with Oxygen (Miami Shores, Fla.: Energy Publications, 2003), 297.
13. Frank Shallenberger, The Principles and Applications of Ozone/UVB Therapy (Carson City, Nev.: Frank Shallenberger, 1999), 13–14.
14. Velio Bocci, “Ozonetherapy Today,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 14.
15. Letter from Velio Bocci, August 31, 2005.
16. Letter from Velio Bocci, December 7, 2005.
17. International Scientific Committee of Ozone Therapy, Madrid Declaration on Ozone Therapy, 2nd ed. (Madrid: International Scientific Committee of Ozone Therapy, 2015), 27–28.
18. G. A. Boyarinov et al., “Dissolution of Ozone in Physiological Saline,” in Proceedings of the 3rd All-Russian Scientific-Practical Conference: Ozone & Methods of Efferent Therapy in Medicine (Nizhny Novgorod, 1998), 6–9.
19. Ibid., 9–11.
20. Letter from Natalia Berdnikova, January 10, 2006.
21. Letters from Velio Bocci, December 7, 2005, and January 10, 2006.
22. Letter from Renate Viebahn-Haensler, February 8, 2006.
23. Letter from Velio Bocci, January 10, 2006.
24. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 189–97.
25. N. Di Paolo et al., “Extracorporeal Blood Oxygenation and Ozonation: Clinical and Biological Implications of Ozone Therapy,” Redox Report: Communications in Free Radical Research 10, no. 3 (2005): 121–30.
26. International Scientific Committee of Ozone Therapy, Madrid Declaration on Ozone Therapy, 2nd ed. (Madrid: International Scientific Committee of Ozone Therapy, 2015), 26–27.
27. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 176–77.
28. Denise Grady, “Gain Reported in Combating Ovary Cancer,” New York Times (January 5, 2006): A1.
29. Silvia Menéndez et al., Ozono: Aspectos básicos y aplicaciones clínicas (Havana: Centro de Investigaciones del Ozono, 2008), 116.
30. S. Schulz et al., “Ozone Therapy in a Cancer Model (VX2 Carcinoma: Head And Abdomen) in Rabbits: A Pilot Study,” presented at the 4th International Symposia on Ozone Applications, Havana, Cuba, 2004; M. Bette et al., “Efficiency of Tazobactem/Piperacillan in Lethal Peritonitis Is Enhanced after Preconditioning of Rats with O3/ O2-Pneumoperitoneum,” Shock 25, no. 1 (January 2006): 23–29.
31. Silvia Menéndez et al., Ozono: Aspectos básicos y aplicaciones clínicas (Havana: Centro de Investigaciones del Ozono, 2008), 122.
32. S. N. Gorbunov et al., “The Use of Ozone in the Treatment of Children Suffered Due to Different Catastrophies,” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-3-31-33.
33. Horst Kief, The Autohomologous Immune Therapy (Ludwigshafen, Germany: Kief Clinic, 1992).
34. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 306.
35. Ibid., 139.
CHAPTER 6. HYDROGEN PEROXIDE
1. Ed McCabe, Flood Your Body with Oxygen (Miami Shores, Fla.: Energy Publications, 2003), 34.
2. Anthony di Fabio, Supplement to the Art of Getting Well, chap. 3 (Franklin, Tenn.: Rheumatoid Disease Foundation, 1989), 17.
3. C. H. Farr, Protocol for the Intravenous Administration of Hydrogen Peroxide (Oklahoma City, Okla.: International Bio-Oxidative Medicine Foundation, 1993), 29–31.
4. McGraw-Hill Encyclopedia of Science and Technology, vol. 12, 6th ed. (New York: McGraw-Hill, 1987), 596.
5. “Hydrogen Peroxide and Peroxyacetic Acid,” Pesticides: Topical & Chemical Fact Sheets (Washington, D.C.: U.S. Environmental Protection Agency, 2005).
6. Hydrogen Peroxide Power Sources (China Lake, Calif.: Naval Air Warfare Center Weapons Division, 2005).
7. Letter from Randall Prue to Oxytherapy.com, March 15, 1996.
8. Hydrogen Peroxide Uses in Agriculture (Glencoe, Minn.: Farmgard Products, n.d.).
9. “Sterilization Methods and Impact on Electronics in Medical Devices,” EE Times (July 8, 2011), www.eetimes.com/document.asp?doc_id=1278906 (accessed October 22, 2016).
10. David Godkin, “Tso3’s Sterizone Seen as Revolutionary Weapon in the Treatment of Superbugs, Other Bacteria,” Medical Device Daily, July 26, 2016, https://medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&forceid=93272 (accessed October 22, 2016); “STERIZONE®VP4Sterilizer,” www.tso3.com/products/sterizone-vp4 (accessed October 22, 2016).
CHAPTER 7. HYDROGEN PEROXIDE IN MEDICINE
1. I. N. Love, “Peroxide of Hydrogen as a Remedial Agent,” The Journal of the American Medical Association (March 3, 1888): 262–65.
2. P. R. Cortelyou, “80 Years Ago: Using Peroxide of Hydrogen in Diseases of the Throat and Nose,” Journal of the Medical Association of Georgia (September 1968): 449–50. [Original article appeared in 1888.]
3. T. H. Oliver and D. V. Murphy, “Influenzal Pneumonia: The Intravenous Use of Hydrogen Peroxide,” Lancet (February 21, 1920): 432–33.
4. Ed McCabe, Flood Your Body with Oxygen (Miami Shores, Fla.: Energy Publications, 2003), 132.
5. J. W. Finney et al., “Protection of the Ischemic Heart with DMSO Alone or DMSO with Hydrogen Peroxide,” Annals of the New York Academy of Sciences 151 (1967): 231–41.
6. H. C. Urschel Jr., Circulation 31, supp. 2 (1965): 203–10.
7. H. C. Urschel Jr., “Cardiovascular Effects of Hydrogen Peroxide,” Diseases of the Chest 51 (February 1967): 187–88.
8. Nathaniel Altman,Oxygen Healing Therapies (Rochester, Vt.: Healing Arts Press, 1998), x.
9. C. H. Farr, Protocol for the Intravenous Administration of Hydrogen Peroxide (Oklahoma City, Okla.: International Bio-Oxidative Medicine Foundation, 1993), 32.
10. Nathaniel Altman,Oxygen Healing Therapies (Rochester, Vt.: Healing Arts Press, 1998), x–xi.
11. C. H. Farr, Protocol for the Intravenous Administration of Hydrogen Peroxide (Oklahoma City, Okla.: International Bio-Oxidative Medicine Foundation, 1993), 32, 38–39.
12. S. P. Chaki and M. M. Misro, “Assessment of Human Sperm Function after Hydrogen Peroxide Exposure: Development of a Vaginal Contraceptive,” Contraception (September 2002): 187–92.
13. K. Brudzynski, “Effect of Hydrogen Peroxide on Antibacterial Activities of Canadian Honeys,” Canadian Journal of Microbiology 52 (2006): 1228.
14. Patricia E. Lusby et al., “Activity of Honeys against Medically Significant Bacteria,” Archives of Medical Research 36, no. 5 (September–November 2005): 464.
15. K. L. Allen, P. C. Molan, and G. M. Reid, “A Survey of the Antibacterial Activity of Some New Zealand Honeys,” Journal of Pharmacy and Pharmacology 43 (1991): 817–822.
CHAPTER 8. HOW IS HYDROGEN PEROXIDE AD MINISTERED?
1. Quoted in Anthony di Fabio, Supplement to the Art of Getting Well, chap. 3 (Franklin, Tenn.: Rheumatoid Disease Foundation, 1989), 15.
2. Oxidative Therapy (Oklahoma City, Okla.: International Bio-Oxidative Medicine Foundation, n.d.), 3.
3. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 355.
4. Betsy Russell-Manning, ed., Self-Treatment for AIDS, Oxygen Therapies, Etc. (San Francisco: Greensward Press, 1988), 19.
5. Kurt Donsbach, Oxygen–Peroxides–Ozone (Tulsa, Okla.: Rockland Corp., 1993), 44–45.
6. Conrad LeBeau, Hydrogen Peroxide Therapy, 9th ed. (Monterey, Calif.: Conrad LeBeau, 1993), 8–9.
7. Kurt Donsbach, Oxygen–Peroxides–Ozone (Tulsa, Okla.: Rockland Corp., 1993), 45.
8. Letter from Charles H. Farr, February 4, 1994.
9. Y. Oya et al., “The Biological Activity of Hydrogen Peroxide,” Mutation Research 172 (1986): 245–53.
10. Letter from Velio Bocci, December 12, 2005.
11. Bill Thomson, “Do Oxygen Therapies Work?” EastWest (September 1989): 110.
12. C. H. Farr, The Use of Hydrogen Peroxide to Inject Trigger Points, Soft Tissue Injuries and Inflamed Joints (Oklahoma City, Okla.: C. H. Farr, 1993).
13. C. H. Farr, Protocol for the Intravenous Administration of Hydrogen Peroxide (Oklahoma City, Okla.: International Bio-Oxidative Medicine Foundation, 1993), 9.
CHAPTER 9. HYPERBARIC OXYGEN THERAPY AND OXYGEN MULTISTEP THERAPY
1. Felicity Barringer, “Under Strain, Towns Prepare for 12 Funerals,” New York Times (January 8, 2006): 17; Paul H. B. Shin and Corky Siemaszko, “Using Meds & Music to Help Miner,” New York Daily News (January 7, 2006): 2.
2. Richard A. Neubauer and Morton Walker, Hyperbaric Oxygen Therapy (Garden City Park, N.Y.: Avery Publishing Group, 1998).
3. Michelle Reillo, AIDS under Pressure (Seattle, Wash.: Hogrefe & Huber Publishers, 1998).
4. Pamela S. Grim et al., “Hyperbaric Oxygen Therapy,” Journal of the American Medical Association (April 25, 1990): 216.
5. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 361.
6. Von Ardenne Institut für Angewandte Medizinische Forschung GmbH, “Oxygen Multistep Therapy,” http://med.ardenne.de/?therapien=oxygen-multistep-therapy&lang=en (accessed February 15, 2016).
7. Exercise with Oxygen Training, www.ewot.com (accessed February 15, 2016).
PART 2. OXIDATIVE THERAPIES IN MEDICINE
1. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 371.
2. J. Varro, “Ozone Applications in Cancer Cases,” in Medical Applications of Ozone, ed. Julius LaRaus (Stamford, Conn.: International Ozone Association, Pan American Committee, 1983), 98.
3. Paul A. Sergios, One Boy at War: My Life in the AIDS Underground (New York: Alfred A. Knopf, 1993), 84.
4. Ibid.
5. Sheryl Gay Stolberg, “U.S. AIDS Research Abroad Sets Off Outcry over Ethics,” New York Times (September 18, 1997): A1.
CHAPTER 10. CARDIOVASCULAR DISEASES
1. E. Riva Sanseverino, E. Castellacci, and P. Castellacci, “Oxygen-Ozone Therapy and Physical Activity in Humans,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 65–72.
2. F. Hernández et al., “Decrease of Blood Cholesterol and Stimulation of Antioxidative Response in Cardiopathy Patients Treated with Endovenous Ozone Therapy,” Free Radical Biology & Medicine 19 (July 1995): 115–19.
3. E. I. Sycheva et al., “[The influence of ozone therapy on oxygen metabolism kinetics and the microcirculation system during spa and resort treatment of the post-infarction patients],” Voprosy kurortologii, fizioterapii, i lechebnoÄ fizicheskoÄ kultury 58, no. 6 (November–December 2013): 9–13.
4. Davor Huic, “Nicaragua’s Ortega in Cuba for Medical Check,” Reuters News Service (February 1, 1996).
5. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 122.
6. R. T. Canoso et al., “Hydrogen Peroxide and Platelet Function” Blood 43, no. 5 (May 1974).
7. B. N. Setty et al., “Effects of Hydrogen Peroxide on Vascular Arachidonic Acid Metabolism,” Prostaglandins, Leukotrienes, and Medicine 14 (1984): 205–13; P. H. Levine et al., “Leukocyte-Platelet Interaction,” Journal of Clinical Investigation 57 (April 1976): 955–63.
8. C. H. Farr, “The Therapeutic Use of Hydrogen Peroxide,” Townsend Letter for Doctors (July 1987): 185.
9. Renate Viebahn-Haensler, “The Biochemical Processes Underlying Ozone Therapy,” Ozonachrichten (January 4, 1985): heft 1/2.
10. N. I. Zhulina et al., “Ozonotherapy Efficiency in the Treatment of Patients with Atherosclerosis of Coronary and Cerebral Vessels,” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-2-9-11.
11. G. Martínez-Sánchez et al., “Effects of Ozone Therapy on Haemostatic and Oxidative Stress Index in Coronary Artery Disease,” European Journal of Pharmacology 69 (September 15, 2012): 156–62.
12. Frank Hernández et al., “Decrease of Blood Cholesterol and Stimulation of Antioxidative Response in Cardiopathy Patients Treated with Endovenous Ozone Therapy,” Free Radical Biology and Medicine (July 1995): 115–19.
13. G. Verrazzo et al., “Hyperbaric Oxygen, Oxygen-Ozone Therapy, and Rheologic Parameters of Blood in Patients with Peripheral Occlusive Arterial Disease,” Undersea & Hyberbaric Medicine (March 1995): 17–22.
14. O. Rokitansky, “The Clinical Effects and Biochemistry of Ozone Therapy in Peripheral Arterial Circulatory Disorders,” in Medical Applications of Ozone, ed. Julius LaRaus (Stamford, Conn.: International Ozone Association, Pan American Committee, 1983), 33–54.
15. A. Romero et al., “La Ozonoterapia en la Atersclerosis Obliterante,” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 70–76.
16. J. Sroczynski et al., “[Various Parameters of Lipid Metabolism after Intra-arterial Injections of Ozone in Patients with Ischemia of the Lower Extremities and Diabetes Mellitus],” Polski Tygodnik Lekarski (November 19–26, 1990): 953–55. [In Polish.]
17. B. Turczynski et al., “[Ozone Therapy and Viscosity of Blood and Plasma, Distance of Intermittent Claudication and Certain Biochemical Plasma Components in Patients with Occlusive Arteriosclerosis of the Lower Limbs],” Polski Tygodnik Lekarski (September 9–30, 1991): 700–703. [In Polish.]
18. J. Sroczynski et al., “[Clinical Assessment of Treatment Results for Atherosclerotic Ischemia of the Lower Extremities with Intraarterial Ozone Injections],” Polski Tygodnik Lekarski (October 19, 1992): 964–66. [In Polish.]
19. S. N. Gorbunov et al., “Medical Ozone in the Treatment of Lower Extremities Peripheral Circulation Disorders,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 109–10.
20. O. V. Maslennikov et al., “[Effect of Ozone Therapy on Hemostatic Changes in Patients with Vascular Atherosclerosis],” Klinicheskaia Meditsina 75, no. 10 (1997): 35–37. [In Russian.]
21. Oleg V. Maslennikov et al., Ozone Therapy in Practice: Health Manual (Nizhny Novgorod: Ministry of Health Service of the Russian Federation, 2008), 21–22.
22. A. Romero et al., “Arteriosclerosis Obliterans and Ozone Therapy: Its Administration by Different Routes,” Angiologia (September–October 1993): 177–79.
23. R. Giunta et al., “Ozonized Autohemotransfusion Improves Hemorheological Parameters and Oxygen Delivery to Tissues in Patients with Peripheral Occlusive Arterial Disease,” Annals of Hematology 80 (December 2001): 745–48.
24. B. Clavo et al., “Effect of Ozone Therapy on Muscle Oxygenation,” Journal of Alternative and Complementary Medicine (April 2003): 251–56.
25. B. A. Korolyov et al., “Ozone Application by Cardiosurgical Patients in Correction of Heart Defects, Complicated by Infectious Endocarditis,” Ozone in Biology and Medicine (Nizhny Novgorod: Ministry of Public Health of Russian Federation, 1992), 88.
26. J. W. Finney et al., “Removal of Cholesterol and Other Lipids from Experimental Animal and Human Atheromatous Arteries by Dilute Hydrogen Peroxide,” Angiology 17 (April 1966): 223–28.
27. F. Hernandez et al., “Decrease of Blood Cholesterol and Stimulation of Antioxidative Response in Cardiopathy Patients with Endovenous Ozone Therapy,” Free Radical Biology & Medicine (July 1995): 115–19.
28. H. C. Urschel Jr., “Cardiovascular Effects of Hydrogen Peroxide: Current Status,” Diseases of the Chest 51 (February 1967): 187–88.
29. J. W. Finney et al., “Protection of the Ischemic Myocardium with DMSO Alone or in Combination with Hydrogen Peroxide,” Annals of the New York Academy of Sciences (1967).
30. S. P. Peretyagin, “Mechanisms of Ozone Medicinal Effect in Case of Hypoxy,” in Ozone in Biology and Medicine (Nizhny Novgorod: Ministry of Public Health of Russian Federation, 1992), 76.
31. F. Devesa et al., “Ozone Therapy in Ischemic Cerebro-Vascular Disease,” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-4-10-18.
32. Bernardino Clavo et al., “Ozone Therapy on Cerebral Blood Flow: A Preliminary Report,” Evidence-Based Complementary and Alternative Medicine 1, no. 3 (2004): 315.
33. Bernardino Clavo et al., “Brain Ischemia and Hypometabolism Treated by Ozone Therapy,” Forsch Komplementmedizine 18 (2011): 283–287.
34. Oleg V. Maslennikov et al., Ozone Therapy in Practice: Health Manual (Nizhny Novgorod: Ministry of Health Service of the Russian Federation, 2008), 22–23.
35. Gerd Wasser, “Additional Therapy of Cerebro-Vascular Disorder (Here: Acute Brain Stroke) by Ozone Therapy,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 91–95.
CHAPTER 11. CANCER
1. S. Thomas, et al., “CD24 Is an Effector of HIF-1–Driven Primary Tumor Growth and Metastasis,” Cancer Research 72, no. 21 (November 1, 2012): 5600–12.
2. J. Cui et al., “Hypoxia and Miscoupling between Reduced Energy Efficiency and Signaling to Cell Proliferation Drive Cancer to Grow Increasingly Faster,” Journal of Molecular Cell Biology 4 (2012): 174–76.
3. Renate Viebahn-Haensler, The Use of Ozone in Medicine, 4th English ed. (Iffezheim, Germany: ODREI-Publishers, 2002), 89.
4. Otto Warburg, The Prime Cause and Prevention of Cancer (Wurzburg, Germany: K. Tritsch, 1966).
5. James D. Watson, Molecular Biology of the Gene (New York: W. A. Benjamin, 1965), 469.
6. J. Varro, “Die Krebsbehandlung mit Ozon,” Erfahrungsheilkunde 23 (1974): 178–81.
7. F. Sweet et al., “Ozone Selectively Inhibits Growth of Cancer Cells,” Science 209 (August 22, 1980): 931–32.
8. Betsy Russell-Manning, ed., Self-Treatment for AIDS, Oxygen Therapies, Etc. (San Francisco: Greensward Press, 1988), 23.
9. J. T. Mallams et al., “The Use of Hydrogen Peroxide as a Source of Oxygen in a Regional Intra-Arterial Infusion System,” Southern Medical Journal (March 1962).
10. B. L. Aronoff et al., “Regional Oxygenation in Neoplasms,” Cancer 18 (October 1965): 1250.
11. H. Sasaki et al., “Application of Hydrogen Peroxide to Maxillary Cancer,” Yonago Acta Medica 11, no. 3 (1967): 149.
12. C. F. Nathan et al., “Extracellular Cytolysis by Activated Macrophages and Granulocytes,” Journal of Experimental Medicine 149 (January 1979): 109.
13. C. F. Nathan and Z. A. Cohn, “Antitumor Effects of Hydrogen Peroxide in Vivo,” Journal of Experimental Medicine 154 (November 1981): 1551.
14. M. K. Samoszuk et al., “In Vitro Sensitivity of Hodgkins Disease to Hydrogen Peroxide Toxicity,” Cancer 63 (1989): 2114.
15. N. C. Nicholson et al., “Hydrogen Peroxide Inhibits Giant Cell Tumor and Osteoblast Metabolism In Vitro,” Clinical Orthopedics and Related Research 347 (February 1998): 250–60.
16. M. C. Symonds et al., “Hydrogen Peroxide: A Potent Cytotoxic Agent Effective in Causing Cellular Damage and Used in the Possible Treatment for Certain Tumors,” Medical Hypotheses 57 (July 2001): 56–58.
17. I. O. Farah and R. A. Begum, “Effect of Nigella sativa (N. sativa L.) and Oxidative Stress on the Survival Pattern of MCF-7 Breast Cancer Cells,” Biomedical Sciences Instrumentation 39 (2003): 359–64.
18. M. Arnan and L. E. DeVries, “Effect of Ozone/Oxygen Gas Mixture Directly Injected into the Mammary Carcinoma of the Female C3H/HEJ Mice,” in Medical Applications of Ozone, ed. Julius LaRaus (Norwalk, Conn.: International Ozone Association, Pan American Committee, 1983), 101–7.
19. F. Sweet et al., “Ozone Selectively Inhibits Growth of Cancer Cells,” Science 209 (August 22, 1980).
20. J. Varro, “Die Krebsbehandlung mit Ozon,” Erfahrungsheilkunde 23 (1974): 94–95.
21. Ibid., 97–98.
22. Kurt W. Donsbach and H. R. Alsleben, Wholistic Cancer Therapy (Tulsa, Okla.: Rockland Corporation, 1992), 49.
23. Kurt W. Donsbach, Oxygen–Peroxides–Ozone (Tulsa, Okla.: Rockland Corporation, 1993), 66.
24. Letter from Kurt W. Donsbach, December 30, 1993.
25. Interview with Jon Greenberg, December 21, 1993.
26. Interview with Horst Kief, December 15, 1993.
27. Ibid.
28. Horst Kief, Treatment of Malignant Diseases with AHIT-aM (Ludwigshafen, Germany: FBM-PHARMA GmbH, 2003), 9.
29. Luis Borrego et al., “Ozono Mas Cobaltoterapia en Pacientes con Adrenocarcinoma Prostatico,” Revista CENIC Ciencias Biologicas 29, no. 3 (1998): 137–40.
30. Guennadi O. Gretchkanev et al., “Medical Ozone for Prophylaxis and Treatment of Complications Associated [with] Chemotherapy [for] Ovarian Cancer,” in Ozone in Medicine, vol. 3 of Proceedings of the 15th Ozone World Congress, London (London: International Ozone Association, 2001).
31. N. A. Terekhina et al., “[The Activity of Adenosinetriphosphatase of Erythrocites in Peripheral Blood of Patients with Colorectal Cancer],” Klinicheskaia Laboratornaia Diagnostika 5 (May 2005): 20–22. [In Russian.]
32. B. Clavo et al., “Intravesical Ozone Therapy for Progressive Radiation-Induced Hematuria,” Journal of Alternative and Complementary Medicine 11 (June 2005): 539–41.
33. B. Clavo et al., “Ozone Therapy in the Management of Persistent Radiation-Induced Rectal Bleeding in Prostate Cancer Patients,” Evidence-Based Complementary and Alternative Medicine (2015): 1–7.
34. Lionel Resnick et al., “Topical Sulindac Combined with Hydrogen Peroxide in the Treatment of Actinic Keratoses,” Journal of Drugs in Dermatology 8, no. 1 (2009): 29–32.
35. V. Bocci et al., “Restoration of Normoxia by Ozone Therapy May Control Neoplastic Growth: A Review and a Working Hypothesis,” Journal of Alternative and Complementary Medicine 11 (April 2005): 257–65.
36. Letter from Velio Bocci, December 28, 2005.
37. International Scientific Committee of Ozone Therapy, Madrid Declaration on Ozone Therapy, 2nd ed. (Madrid: International Scientific Committee of Ozone Therapy, 2015): 30.
38. Carl Franklin, “Oxygen Is Key to Tumor Treatment,” New Scientist (May 7, 1994): 17.
39. S. Schulz et al., “Ozone Therapy in a Cancer Model (VX2 Carcinoma: Head and Abdomen) in Rabbits: A Pilot Study,” presented at the 4th International Symposia on Ozone Applications, Havana, Cuba, 2004.
CHAPTER 12. HIV /AI DS
1. Resource Needs for an Expanded Response to AIDS in Low- and Middle-Income Countries (New York: Joint United Nations Programme on HIV/ AIDS, 2005), 3.
2. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 253.
3. Siegfried Rilling and Renate Viebahn, The Use of Ozone in Medicine (Heidelberg, Germany: Haug Publishers, 1987), 41–44.
4. “HIV Clue Announced,” American Medical News (March 1, 1993): 25.
5. Health Facts (July 1992): 4.
6. Interview with Juliane Sacher, January 26, 1994.
7. Letter from Velio Bocci, January 6, 2006.
8. Letter from Frank Shallenberger, December 9, 1993.
9. M. T. Carpendale and J. K. Freeberg, “Ozone Inactivates HIV at Non-Cytotoxic Concentrations,” Antiviral Research 16 (1991): 281–92.
10. K. H. Wells et al., “Inactivation of Human Immunodeficiency Virus Type I by Ozone In Vitro,” Blood 78, no. 7 (October 1, 1991): 1882.
11. G. V. Kornilaeva et al., “Ozone Influence on HIV Infection In Vitro,” in Ozone in Biology and Medicine (Nizhny Novgorod, Russia: Ministry of Public Health of Russia Federation, 1992), 86.
12. A. C. Baggs, “Are Worry-Free Transfusions Just a Whiff of Ozone Away?” Canadian Medical Association Journal (April 1, 1993): 1159.
13. M. E. Shannon, interview in Ozone and the Politics of Medicine (Vancouver: Threshold Film, 1993).
14. Horst Kief, “Die Biologischen Grundlagen der Autohomologen Immunotherapie,” Erfahrungsheilkunde 37, no. 7 (July 1988): 175–80.
15. Horst Kief, interview in Ozone and the Politics of Medicine (Vancouver: Threshold Film, 1993).
16. Alexander Pruess, “Positive Treatment Results in AIDS Therapy,” Ozonachrichten 5 (1986): 1, 2, 3–5.
17. Horst Kief, Ozone and the Auto-homologous Immune Therapy in AIDS Patients (Ludwigshafen, Germany: Kief Clinic, 1993).
18. M. T. Carpendale and J. Griffiss, “Is There a Role for Medical Ozone in the Treatment of HIV and Associated Infections?” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-1-38-43.
19. M. T. Carpendale et al., “Does Ozone Alleviate AIDS Diarrhea?” Journal of Clinical Gastroenterology 17 (1993): 142–45.
20. FrankShallenberger, “Intravenous Ozone Therapy in HIV-related Disease,” in Proceedings of the 4th International Bio-Oxidative Medicine Conference (Oklahoma City, Okla.: IBOM, 1993).
21. Case Studies (Salisbury, N.C.: Cure AIDS Now, 1993).
22. John C. Pittman, Introduction (Salisbury, N.C.: Cure AIDS Now, 1993), 2.
23. Michelle Reillo, AIDS under Pressure (Seattle, Wash.: Hogreve & Huber Publishers, 1997), 24.
24. Ibid., 6.
25. Ibid., 94–96.
26. Ibid., 98.
27. G. E. Garber et al., “The Use of Ozone Treated Blood in the Therapy of HIV Infection and Immune Disease,” AIDS 5 (1991): 981–84.
28. Letter from Michael E. Shannon, January 21, 1994.
29. Letter from M. E. Shannon to Ed McCabe, January 13, 1995.
30. Interview with Silvia Menendez, January 6, 1994.
31. G. P. Miley et al., “Ultraviolet Blood Irradiation Therapy of Apparently Intractable Bronchial Asthma,” Archives of Physical Medicine 27 (1946): 24–29; G. P. Miley and J. A. Christensen, “Ultraviolet Blood Irradiation Therapy in Acute Virus and Virus-Like Infections,” Review of Gastroenterology 15, no. 4 (1948): 271–77; V. P. Wasson et al., “Ultraviolet Blood Irradiation Therapy (Knott Technic) in Rheumatic Fever in Children,” Experimental Medicine and Surgery 8 (1950): 15–33; and R. C. Olney et al., “Treatment of Viral Hepatitis with the Knott Technic of Blood Irradiation,” American Journal of Surgery 90, no. 3 (1955): 402–9.
32. P. Morel et al., “Photochemical Inactivation of Viruses and Bacteriophage in Plasma and Plasma Fractions,” Blood Cells 18 (1992): 27–41; F. Knutson et al., “Photochemical Inactivation of Bacteria and HIV in Buffy-Coat-Derived Platelet Concentrates under Conditions That Preserve In Vitro Platelet Function,” Vox Sanguinis 78, no. 4 (2004): 209–16; C. T. Jordan et al., “Photochemical Treatment of Platelet Concentrates with Amotosalen Hydrochloride and Ultraviolet A Light Inactivates Free and Latent Cytomegaovirus in a Murine Transfusion Model,” Transfusion 44, no. 8 (August 2004): 1159–65; and L. Lin et al., “Inactivation of Viruses in Platelet Concentrates by Photochemical Treatment with Amotosalen and Long-Wavelength Ultraviolet Light,” Transfusion 45, no. 4 (April 2005): 580–90.
33. Robert Jay Rowan, “Ultraviolet Blood Irradiation Therapy (Photo-Oxidation): The Cure That Time Forgot,” International Journal of Biosocial Medical Research 14, no. 2 (1996): 128.
34. A Special Report from Keep Hope Alive no. 4 (December 13, 1993), 2.
35. M. T. Carpendale and J. Griffiss, “Is There a Role for Medical Ozone in the Treatment of HIV and Associated Infections?” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-1-38.
36. Mark Konlee and Conrad LeBeau, Immune Restoration Handbook, 2nd ed. (West Allis, Wis.: Keep Hope Alive, 2004), 206.
37. Velio Bocci, “A Reasonable Approach for the Treatment of HIV Infection in the Early Phase with Ozonetherapy (Autohaemotherapy): How ‘Inflammatory’ Cytokines May Have a Therapeutic Role,” Mediators of Inflammation 3 (1994): 315–21.
38. Velio Bocci, Iacopo Zanardi, and Valter Travagli, “Ozonation of Human HIV-infected Plasmas for Producing a Global Vaccine: How HIV-patients May Help Fight the HIV Pandemia,” Virulence 1, no. 3 (2010): 215–17.
39. Statement by Randolph F. Wykoff before the Committee on the Judiciary, Subcommittee on Crime and Criminal Justice, U.S. House of Representatives, May 23, 1993.
40. Testimony by Richard Schrader on AIDS fraud before the Committee on the Judiciary, Subcommittee on Crime and Criminal Justice, U.S. House of Representatives, May 23, 1993.
CHAPTER 13. INFECTIOUS DISEASES
1. P. Madej et al., “Ozonotherapy,” Materia Medica Polona 27 (April–June 1995): 53–56.
2. Kenneth Bock, “Oxidative Therapies in Lyme Disease,” presentation at the 8th International Bio-Oxidative Medicine Conference, Anchorage, Alaska (May 18, 1997).
3. I. T. Vasilyev, “Perspectives of Ozone Application in the Treatment of Diffused Peritonitis,” in Ozone in Biology and Medicine (Nizhny Novgorod, Russia: Ministry of Public Health of Russia Federation, 1992), 89.
4. V. I. Bulynin and A. A. Glukhov, “[Treatment of Peritonitis Using Ozone and Hydropressive Technology],” Khirirgiia 7 (1999): 9–11. [In Russian.]
5. H. Konrad, “Ozone vs. Hepatitis and Herpes,” in Medical Applications of Ozone, ed. Julius LaRaus (Norwalk, Conn.: International Ozone Association, Pan American Committee, 1983), 140–41.
6. Y. Betancourt et al., “Ozone Therapy: A Useful Alternative on Virulent Hepatitis Treatment,” in Abstracts: 2nd International Symposium on Ozone Applications (Havana, Cuba: Ozone Research Center/National Center for Scientific Research, 1997), 61–62.
7. Ronald M. Davis, untitled monograph, 5002 Todville, Seabrook, TX 77586.
8. Velio Bocci, Ozone: A New Medical Drug (Dordrecht, Netherlands: Springer, 2005), 112–13.
9. M. Nabil Mawsouf et al., Ozone Therapy in Patients with Hepatitis “C”: A Clinical Study (Cairo: First International Congress of Ozone and Medicine, 2006).
10. Oleg V. Maslennikov et al.,Ozone Therapy in Practice: Health Manual (Nizhny Novgorod: Ministry of Health Service of the Russian Federation, 2008), 29.
11. S. Zaky et al., “Preliminary Results of Ozone Therapy as a Possible Treatment for Patients with Chronic Hepatitis C,” Journal of Alternative and Complementary Medicine 17, no. 3 (March 2011): 259–63.
12. X. B. Gu et al., “Effect of Medical Ozone Therapy on Renal Blood Flow and Renal Function of Patients with Chronic Severe Hepatitis,” Chinese Medical Journal 123, no. 18 (September 2010): 2510–13.
13. C. H. Farr, Rapid Recovery from Type A/Shanghai Influenza Treated with Intravenous Hydrogen Peroxide (Oklahoma City, Okla.: C. H. Farr, 1993).
14. Joseph Mercola, website citation, Optimal Wellness Center, www.mercola.com (accessed January 2006).
15. C. H. Farr, The Therapeutic Use of Intravenous Hydrogen Peroxide (Oklahoma City, Okla.: Genesis Medical Center, 1987), 18–19.
16. D. A. Blaine and M. A. Frable, “Mucormycosis: Adjunctive Therapy with Hydrogen Peroxide,” Virginia Medical Quarterly: VMQ 123, no. 1 (Winter 1996): 30–32.
17. Silvia Menendez et al., “Onicomycosis Treated with Ozonized Oil,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 279–82.
18. Silvia Menéndez et al., “Therapeutic Efficacy of Topical OLEOZON® in Patients Suffering from Onychomycosis,” Mycoses 54, no. 5 (September 2011): 272–77.
19. J. O. Sardina et al., “Tratamiento de la Giardiasis Recidivante con Ozono,” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 61–64.
20. Silvia Menendez et al., “Application of Ozonized Oil in the Treatment of Infantile Giardiasis,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 297–300.
21. H. M. Dockrell and H. L. Playfair, “Killing of Blood-Stage Murine Malaria Parasites by Hydrogen Peroxide,” Infection and Immunity (January 1983): 456–59.
22. Bertram Lell et al., “The Activity of Ozone against Plasmodium falciparum,” Ozone Science & Engineering 23 (2001): 89.
23. Adriana Schwartz, “A Possible Solution to Ebola: Ozone Therapy” (Madrid: International Medical Ozone Association, October 7, 2014).
24. Silvia Menéndez Cepero, letter to the author, January 31, 2016.
CHAPTER 14. MUSCULOSKELETAL PROBLEMS
1. R. I. Gracer and V. Bocci, “Can the Combination of Localized ‘Proliferative Therapy’ with ‘Minor Ozonated Autohemotherapy’ Restore the Natural Healing Process?” Medical Hypotheses 65, no. 4 (2005): 752–59.
2. C. H. Siemsen, “The Use of Ozone in Orthopedics,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 125–30.
3. Lamberto Re et al., “Clinical Evidence of Ozone Interaction with Pain Mediators,” Saudi Medical Journal 32, no. 12 (2011): 1363–67.
4. Proceedings of the 10th Ozone World Congress (Monaco, 1991), 87–93.
5. R. Wong et al., “Ozonoterapia Analgesica,” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 143.
6. C. F. Andreula et al., “Minimally Invasive Oxygen-Ozone Therapy for Lumbar Disc Herniation,” ANJR American Journal of Neuroradiology 24, no. 5 (May 2003): 996–1000.
7. M. Gallucci et al., “Sciatica: Treatment with Intradiscal and Intraforaminal Injections of Steroid and Oxygen-Ozone versus Steroid Only,” Radiology 242, no. 3 (March 2007): 907–13.
8. Wei Lu et al., “Treatment of Large Lumbar Disc Herniation with Percutaneous Ozone Injection via the Posterior-lateral Route and Inner Margin of the Facet Joint,” World Journal of Radiology 2 (March 28, 2010): 109–12.
9. L. Xu et al., “Evaluation of the Clinical Curative Effect of an O2-O3 mixture to Treat Lumbar Disc Herniation with Different Treatment Sessions,” Journal of Interventional Neurology 15 (2009): 159–63.
10. Z. Yu et al., “[Targeted Injection of Ozone through the Posterior Approach via the Spinal Canal and Dural Sac for Treating Lumbar Disc Herniation],” [ Journal of Southern Medical University] 32, no. 2 (February 2012): 243–46. [In Chinese.]
11. M. Perri et al., “MRI DWI/ADC Signal Predicts Shrinkage of Lumbar Disc Herniation after O2–O3 Discolysis,” Neuroradiology Journal 2 (April 28, 2015): 198–204.
12. M. Paolini et al., “Intramuscular Oxygen-Ozone Therapy in the Treatment of Acute Back Pain with Lumbar Disc Herniation,” Spine 34, no. 13 (2009): 1337–44.
13. M. Dall’Olio et al., “Oxygen-Ozone Therapy for Herniated Lumbar Disc in Patients with Subacute Partial Motor Weakness Due to Nerve Root Compression,” Interventional Neuroradiology 20 (2014): 547–54.
14. V. Eslami and V. Rahimi-Movaghar, “The Major Efficient Mechanisms of Ozone Therapy Are Obtained in Intradiscal Procedures,” Pain Physician 15 (November/December 2012): 1007.
15. M. D’Erme et al., “[Ozone Therapy in Lumbar Sciatic Pain],” La Radiologia Medica 95, no. 1–2 (January–February 1998): 21–24. [In Italian.]
16. M. Muto et al., “Treatment of Herniated Lumbar Disc by Intradiscal and Intraforaminal Oxygen-Ozone (O2-O3) Injection,” Journal de Neuroradiologie 31, no. 3 (June 2004): 183–89.
17. M. Bonetti et al., “Intraforaminal O2-O3 versus Periradicular Steroidal Infiltrations in Lower Back Pain: Randomized Controlled Study,” ANJR American Journal of Neuroradiology 26, no. 5 (May 2005): 996–1000.
18. M. Bonetti et al., “CT-Guided Oxygen-Ozone Treatment for First Degree Spondylolisthesis and Spondylolysis,” Acta Neurochirurgica 92 (2005): 87–92.
19. K. Gu et al., “Safety and Efficacy Study of an Ozone Laser Combined Therapy Using Puncture Needle in the Treatment of Patients with Cervical Spondylosis,” Journal of Spinal Disorders & Techniques (August 20, 2014).
20. Frank Shallenberger,The Principles and Applications of Ozone/UVB Therapy (Carson City, Nev.: Frank Shallenberger, 1999).
21. Frank Shallenberger,Prolozone Therapy (Carson City, Nev.: Frank Shallenberger, 2003).
22. V. S. Agapov et al., “[Ozone Therapy of Chronic Mandibular Osteomyelitis],” Stomatologiia 80, no. 5 (2001): 14–17. [In Russian.]
23. A. Ceballos, “Tratamiento de la Osteoartritis con Ozono,” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 152.
24. J. H. Li, “[Treatment of Middle-Aged and Aged Patients with Knee Osteoarthritis of Yang-Deficiency Induced Cold-Damp Syndrome by Ozone Combined Chinese Materia Medica: A Clinical Research],” [Chinese Journal of Integrated Traditional and Western Medicine] 33, no. 4 (April 2013): 471–75.
25. American College of Rheumatology (ACR), “Ozone Gas Injections May Do the Trick for Knee Osteoarthritis Sufferers,” ScienceDaily (November 8, 2015), www.sciencedaily.com/releases/2015/11/151108084632.htm (accessed September 15, 2016).
26. Interview with Horst Kief, December 15, 1993.
27. S. Menendez et al., “Ozonoterapia en la Artritis Reumatoidea,” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 144–51.
28. Jon Greenberg, “An Auto-Vaccine for Human Use Produced with the Aid of Ozone Gas,” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-3-21.
29. Mansur Doğan et al., “Effects of High-Frequency Bio-Oxidative Ozone Therapy in Temporomandubular Disorder-related Pain,” Medical Principles and Practice 23 (2014): 507–10.
30. F. Nêuton de Oliveira Magalhães et al. “Effects of Ozone Applied by Spinal Endoscopy in Patients with Chronic Pain Related to Failed Back Surgery Syndrome: APilot Study,” Neuropsychiatric Disease and Treatment 9 (2013): 1759–66.
31. Javier Hidalgo-Tallón et al., “Ozone Therapy as Add-on Treatment in Fibromyalgia Management by Rectal Insufflation: An Open-Label Pilot Study,” Journal of Alternative and Complementary Medicine 18 (2012): 1–5.
CHAPTER 15. NEURODEGENERATIVE DISORDERS
1. M. Rodriguez et al., “Ozone Therapy in the Treatment of Elderly Patients Suffering from Parkinson’s Syndromes,” in Abstracts: 2nd International Symposium on Ozone Applications (Havana, Cuba: Ozone Research Center/National Center for Scientific Research, 1997), 43–44.
2. M. Rodriguez et al., “Ozone Therapy for Senile Dementia,” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-4-19-25.
3. M. Casas et al., “Ozone Therapy in Demential Syndrome in the Elderly,” in Abstracts: 2nd International Symposium on Ozone Applications (Havana, Cuba: Ozone Research Center/National Center for Scientific Research, 1997), 42–43.
4. Interview with Josué García, January 6, 1994.
5. F. Molinari et al., “Ozone Autohemotherapy Induces Long-Term Cerebral Metabolic Changes in Multiple Sclerosis Patients” International Journal of Immunopathology and Pharmacology 27, no. 3 (July–September 2014): 379–89.
CHAPTER 16. DIABETES
1. N. Velasco, “Valor de la Ozonoterapia en el Tratamiento del Pie Diabetico Neuroinfeccioso,” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 64–70.
2. E. Pavlovskaya et al., “Effectiveness of Ozone Therapy in the Process of Diabetes Treatment,” in Abstracts: 2nd International Symposium on Ozone Applications (Havana, Cuba: Ozone Research Center/National Center for Scientific Research, 1997), 50.
3. A. G. Kulikov et al., “[Efficacy of Different Methods of Ozone Therapy in Vascular Complications of Diabetes Mellitus],” Voprosy Kururtologii Fizioterapii 5 (September–October 2002): 17–20. [In Russian.]
4. Oleg V. Maslennikov et al., Ozone Therapy in Practice: Health Manual (Nizhny Novgorod: Ministry of Health Service of the Russian Federation, 2008), 23–24.
5. Ibid.
6. Ibid.
7. Gregorio Martinez-Sanchez et al., “Therapeutic Efficacy of Ozone in Patients with Diabetic Foot,” European Journal of Pharmacology (October 31, 2005): 151.
8. Ibid., 156.
9. M. R. Hayden et al., “Type 2 Diabetes Mellitus as a Conformational Disease,” JOP: Journal of the Pancreas (Online) 6, no. 4 (2004): 28.
10. Velio Bocci et. al., “It Is Time to Integrate Conventional Therapy by Ozone Therapy in Type-2 Diabetes Patients,” Annals of Translational Medicine 2 no. 12 (December 2014): 117.
CHAPTER 17. GYNECOLOGY AND OBSTETRICS
1. T. de la Cagigas et al., “Use of Ozonized Oil on Patients with Vulvovaginitis,” in First Iberolatinamerican Congress on Ozone Applications (Havana, Cuba: National Center on Scientific Research, 1990), 66.
2. T. S. Kachalina et al., “Some Aspects of Ozone Therapy Application in Gynecological Practice,” in Ozone in Biology and Medicine (Nizhny Novgorod: Ministry of Public Health of Russia Federation, 1992), 90.
3. N. M. Pobedinsky et al., “Effectiveness of Ozone Therapy in the Treatment of Condilomatosis in Women,” in Ozone in Biology and Medicine (Nizhny Novgorod: Ministry of Public Health of Russia Federation, 1992), 90.
4. S. J. Winceslaus and G. Calver, “Recurrent Bacterial Vaginosis: An Old Approach to a New Problem,” International Journal of STD & AIDS 7, no. 4 (July 1996): 284–87.
5. G. O. Grechkanyov and T. S. Kachalaina, “Ozone Therapy in a Complex Treatment of Threatened Abortion,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 291–94.
6. V. M. Andikyan et al., “Morphological Changes in the Placenta after Ozone Therapy,” Bulletin of Experimental Biology and Medicine 130, no. 7 (July 2000): 715–18.
7. Guennadi O. Gretchkanev, “Ozonetherapy as the Main Component of the Complex Treatment of Threatened Abortion,” in Proceedings of the 15th World Ozone Congress (London: International Ozone Association, 2001), 229–36.
8. C. He and X. Ma, “Distal Fallopian Tube Recanalization Using Ozone Treatment: A Clinical Study in Two Hundred Tubal Obstruction Chinese Patients,” International Journal of Clinical and Experimental Medicine 9, no. 2 (2015): 2958–61.
CHAPTER 18. LUNG AND BRONCHIAL DISEASES
1. Velio Bocci, Ozone: A New Medical Drug (Dordrecht, Netherlands: Springer, 2005), 193–95.
2. Gilbert Glady, “Diverse Pathology Treated in Medical Ozone Clinic,” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-3-3.
3. Horst Kief, “Die Behandlung des Asthma Bronchiale mit der Autohomologen Immuntherapie (AHIT),” Erfahrungsheilkunde 9 (1990): 534.
4. Frank A. Hernandez Rosales et al., “Ozone Therapy Effects on Blood Biomarkers and Lung Function in Asthma,” Archives of Medical Research 36, no. 5 (September–October 2005): 549–54.
5. Silvia Menéndez et al., Ozono: Aspectos básicos y aplicaciones clínicas (Havana: Centro de Investigaciones del Ozono, 2008), 188.
6. A. A. Priimak, “[The Effect of an Ozone-Oxygen Mixture on Mycobacterium Tuberculosis and Conditionally Pathogenic Microorganisms],” Problemy Tuberkuleza 4 (1991): 7–10. [In Russian.]
7. V. G. Dobkin et al., “[Local Ozone Therapy in the Complex Surgical Treatment of Pulmonary and Pleural Tuberculosis Patients],” Problemy Tuberkuleza 7 (2001): 18–20. [In Russian.]
8. Z. Antoszewski et al., “[Ozone Therapy in the Management of Respiratory Failure after Long-Term Mechanical Respiration],” Polski Merkuriusz Lekarski 11, no. 62 (August 2001): 180–81. [In Polish.]
9. J. Calunga et al., “Rectal Ozone Therapy for Patients with Pulmonary Emphysema,” La Revista Médica de Chile 139 (2011): 439–47.
CHAPTER 19. DISEASES OF THE SKIN
1. Velio Bocci, Ozone: A New Medical Drug (Dordrecht, Netherlands: Springer, 2005), 192–93.
2. S. L. Krivatkin, “The Experience of Ozone Therapy in Dermatovenereological Dispensary,” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-3-5-11.
3. S. L. Krivatkin et al., “Ozonetherapy in Out-Patient Dermatological Practice,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 157–63.
4. M. Miulani et al., “Efficacy and Safety of Stabilized Hydrogen Peroxide Cream (Crystacide) in Mild-to-Moderate Acne Vulgaris: A Randomised, Controlled Trial versus Benzoyl Peroxide Gel,” Current Medical Research and Opinion 19, no. 2 (2003): 135–38.
5. R. Capizzi et al., “Skin Tolerability and Efficacy of Combination Therapy with Hydrogen Peroxide Stabilized Cream and Adapalene Gel in Comparison with Benzoyl Peroxide Cream and Adapalene Gel in Common Acne: A Randomised, Investigator-Masked, Controlled Trial,” British Journal of Dermatology 151, no. 2 (2004): 481–84.
6. E. Riva Sanseverino et al., “Effects of Ozonized Autohemotherapy on Human Hair Cycle,” Panminerva Medica 37 (September 1995): 129–32.
7. Letter from Velio Bocci, January 17, 2006.
8. T. de las Cagigas et al., “Ozonized Oil and Its Efficacy in Epidermophitosis,” in First Iberolatinamerican Congress on Ozone Applications (Havana, Cuba: National Center on Scientific Research, 1990), 63.
9. Heinz Konrad, “Ozone vs. Hepatitis and Herpes,” in Medical Applications of Ozone, ed. Julius LaRaus (Norwalk, Conn.: International Ozone Association, Pan American Committee, 1983), 144.
10. R. Mattassi et al., “Ozone as Therapy in Herpes Simplex and Herpes Zoster Diseases,” in Medical Applications of Ozone, ed. Julius LaRaus (Norwalk, Conn.: International Ozone Association, Pan American Committee, 1983), 136.
11. Ibid., 134.
12. J. Delgado, “Tratamiento con Ozono del Herpes Zoster,” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 160–62.
13. Heinz Konrad, “Ozone vs. Hepatitis and Herpes,” in Medical Applications of Ozone, ed. Julius LaRaus (Norwalk, Conn.: International Ozone Association, Pan American Committee, 1983), 147.
14. Ibid., 189.
15. M. Franzini et al., “Subcutaneous Oxygen-Ozone Therapy in Indurative Hypodermatitis and in Localized Lipodystrophies: A Clinical Study of Efficiency and Tolerability,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 131–43.
16. Horst Kief, “Die Behandlung der Neurodermatitis mit Autohomologer Immuntherapie (AHIT),” Erfahrungsheilkunde 1 (1989).
17. Horst Kief, “Die Behandlung der Neurodermatitis mit AHIT,” Erfahrungsheilkunde 3a (March 1993): 166–89.
18. O. B. Christiansen and S. Anehus, “Hydrogen Peroxide Cream: An Alternative to Topical Antibiotics in the Treatment of Impetigo Contagiosa,” Acta Dermato-venereologica 74 (November 1994): 460–62.
19. S. I. Ahmad, “Control of Skin Infections by a Combined Action of Ultraviolet A (from Sun or UV Lamp) and Hydrogen Peroxide (HUVA Therapy) with Special Emphasis on Leprosy,” Medical Hypotheses 57 (October 2001): 484–86.
20. Felipe J. J. Reis et al., “The Use of Ozone in High Frequency Device to Treat Hand Ulcers in Leprosy: A Case Study,” Tropical Medicine and Health 43, no. 3 (2015): 195–99.
21. M. Manok, “[On a Simple and Painless Treatment of Warts],” Hautarzt 12 (September 1961): 425. [In German.]
22. T. de la Cagigas et al., “Therapy with Ozonized Oil in Ulcers in Lower Limbs,” in First Iberolatinamerican Congress on Ozone Applications (Havana, Cuba: National Center on Scientific Research, 1990), 64.
23. Lamberto Re et al., “Stevens-Johnson Syndrome Treated with Ozone Hemo Therapy: A Case Report,” International Journal of Medical and Pharmaceutical Case Reports 4, no. 4 (2015): 92–96.
24. R. Zanardi et al., “What Is the Best Strategy for Enhancing the Effects of Topically Applied Ozonated Oils in Cutaneous Infections?” BioMed Research International, article ID 702949 (2013): 6 pages.
CHAPTER 20. EYE DISEASES
1. A. Gierek-Lapinska et al., “[Preliminary Report on Using General Ozone Therapy in Diseases of the Posterior Segment of the Eye],” Klinika Oczna (May–June 1992): 139–40. [In Polish.]
2. Silvia Menendez et al., “Ozone Therapy and Magneto Therapy: New Methods for the Rehabilitation of Patients with Simple Chronic Glaucoma,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 99–106.
3. Rosaralis Santiesteban et al., “Ozone Therapy in Optic Nerve Dysfunction,” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-4-1-9.
4. Rosaralis Santiesteban et al., “Ozone Therapy in Patients Suffering from Optic Nerve Dysfunction,” in Abstracts: 2nd International Symposium on Ozone Applications (Havana, Cuba: Ozone Research Center/National Center for Scientific Research, 1997), 40.
5. E. Riva Sanseverino et al., “Effects of Oxygen-Ozone Therapy on Age-Related Degenerative Retinal Maculopathy,” Panminerva Medica (April–June 1990): 77–84.
6. Silvia Menendez et al., “Aplicacion de la Ozonoterapia en la Retinosis Pigmentaria,” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 84–90.
7. E. C. Diaz et al., “Ozone Therapy in Different Ophthalmologic Diseases,” in Abstracts: 2nd International Symposium on Ozone Applications (Havana, Cuba: Ozone Research Center/National Center for Scientific Research, 1997): 38–39.
8. M. Copello et al., “Ten Year Study in Patients Suffering from Retinitis Pigmentosa and Treated with Repeated Cycles of Ozone Therapy,” in Abstracts: 2nd International Symposium on Ozone Applications (Havana, Cuba: Ozone Research Center/National Center for Scientific Research, 1997), 36.
9. Interview with Rosaralis Santiesteban, January 5, 1994.
10. V.V. Neroev et al., “[Effects of Ozone Therapy on the Functional Activity of the Retina in Patients with Involutional Central Chorioretinal Dystrophy],” Vesnik Oftalmologii 119, no. 6 (November–December 2003): 18–21. [In Russian.]
11. Letter from Velio Bocci, January 19, 2006.
12. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 287.
13. E. Borrelli and V. Bocci, “Visual Improvement Following Ozonetherapy in Dry Age Related Macular Degeneration; a Review,” Medical Hypotheses, Discovery & Innovation: Opthamology 2 (2013): 47–51.
CHAPTER 21. DISEASES OF THE EAR
1. Ernesto Basabe et al., “Ozone Therapy Like a Favoring Element in the Rehabilitation of Children with Hearing Loss,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 275–78.
2. P. D. Spraggs et al., “A Prospective Randomized Trial of the Use of Sodium Bicarbonate and Hydrogen Peroxide Ear Drops to Clear a Blocked Tympanostomy Tube,” International Journal of Pediatric Otorhinolaryngology 31 (March 1995): 207–14.
3. I. Ovchinnikov and E. V. Sinkov, “[Use of Gaseous Ozone and Ozonized Solutions in the Treatment of Chronic Suppurative Otitis Media],” Vestnik Otorinolaringologii 6 (1998): 11–12. [In Russian.]
4. K. Pawlak-Osinska et al., “Ozone Therapy and Pressure-Pulse Therapy in Ménière’s Disease,” International Tinnitus Journal 10, no. 1 (2004): 54–57.
5. R. Persaud, “A Novel Approach to the Removal of Superglue from the Ear,” Journal of Laryngology and Otology 115, no. 11 (November 2001): 901–2.
CHAPTER 22. OTHER HEALTH PROBLEMS
1. Velio Bocci, “Ozone as a Bioregulator: Pharmacology and Toxicology of Ozonetherapy Today,” Journal of Biological Regulators and Homeostatic Agents 10 (April–September 1996): 31–53.
2. R. Behar et al., “Tratamiento de la Ulcera Gastrodoudenal con Ozono,” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 60–61.
3. S. Schulz, “The Role of Ozone/Oxygen in Clindamycin-Associated Enterocolitis in the Djungarian Hamster (Phodopus sungorus sungorus),” Laboratory Animals 20 (1986): 41–48.
4. Letter from Siegfried Schulz, January 9, 2006.
5. Y. Geng et al., “[Ozonetherapy Combined with Sulfasalazine Delivered via a Colon Therapy System for Treatment of Ulcerative Colitis].” [ Journal of Southern Medical University], 30, no. 12 (December 2010): 2683–85. [In Chinese.]
6. R. A. Mayer, “Experiences of a Pediatrician Using Ozone as a Chemotherapeutic Agent for the Treatment of Diseases of Children,” in Medical Applications of Ozone, ed. Julius LaRaus (Norwalk, Conn.: International Ozone Association, Pan American Committee, 1983), 210.
7. Silvia Menendez et al., “Application of Ozone Therapy in Children with Humoral Immunity Deficiency,” in Ozone in Medicine, vol. 3 of Proceedings of the 12th World Congress of the International Ozone Association (Zurich: International Ozone Association, 1995), 271–74.
8. I. Parkhisenko and S. V. Bil’chenko, “[The Ozone Therapy in Patients with Mechanical Jaundice of Tumorous Genesis],” Vestnik Khirurgii Imeni I. I. Grekova 162, no. 5 (2003): 85–87. [In Russian.]
9. S. A. Kotov, “[Ozone Therapy of Migraine],” Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova 110, no. 11 (2000): 35–37. [In Russian.]
10. B. Clavo et al., “Long-Term Improvement in Refractory Headache Following Ozone Therapy,” Journal of Alternative and Complementary Medicine 19, no. 5 (2013): 453–58.
11. M. E. Shannon, interview in Ozone and the Politics of Medicine (Vancouver: Threshold Film, 1993).
12. Silvia Menendez et al., “Application of Medical Ozone Therapy in Patients with Sickle Cell Anemia: Preliminary Report,” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-3-12-17.
13. Velio Bocci and Carlo Aldinucci, Rational Bases for Using Oxygen-Ozone Therapy in Sickle-Cell Anemia and ß-Thalassaemia: A Therapeutic Perspective (Siena, Italy: Department of Physiology, Ozonetherapy Centre, University of Siena, 2001), 10.
14. A. I. Muminov and N. Zh. Khushvakova, “[Ozone Therapy in Patients with Chronic Purulent Rhinosinusitis],” Vestnik Otorinolaringologii 6 (2001): 48–49. [In Russian.]
15. G. Bonforte et al., “Ozone Therapy: A Potential Adjunct Approach to Lower Urinary Tract Infection? A Case Series Report,” Giornale Italiano de Nefrologia 30, no. 4 (2013): 1–6.
CHAPTER 23. ACCIDENTS, INJURIES, AND WOUND HEALING
1. J. Ramos et al., “Estudio Imunologico de 25 Pacientes Grandes Quemados Tratados con Ozono,” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 116–20.
2. W. Xie et al., “[The Role of Ozone Solution on Debridement and Sterilization of Burn Wound],” Zhonghua Shao Shang Za Zhi 16, no. 3 (June 2000): 163–65. [In Chinese.]
3. S. I. Ahmad and O. G. Iranzo, “Treatment of Post-Burns Bacterial Infections by Fenton Reagent, Particularly the Ubiquitous Multiple Drug Resistant Pseudomonas Spp.,” Medical Hypotheses 61, no. 4 (October 2003): 431–34.
4. A. Campanati et al., “Topical Ozonated Oil versus Hyaluronic Gel for the Treatment of Partial- to Full-Thickness Second-Degree Burns: A Prospective, Comparative, Single-Blind, Non-randomised, Controlled Clinical Trial,” Burns 39, no. 6 (September 2013): 1178–83.
5. H. Kawalsky et al., “The Use of Ozonotherapy in Nose Correction Operations,” Acta Chirirgiae Plasticae 34, no. 3 (1992): 182–84.
6. E. P. Kudriavtsev et al., “[Ozone Therapy of Diffuse Peritonitis in the Early Postoperative Period],” Khirurgiia no. 3 (1997): 36–41. [In Russian.]
7. H. Al-Saadi et al., “Ozonated Saline Shows Activity against Planktonic and Biofilm Growing Staphylococcus aureus In vitro: A Potential Irrigant for Infected Wounds,” International Wound Journal 13, no. 5 (January 14, 2015): 936–42.
8. H. Calvo et al., “Experiencias Preliminares en la Utilizacion del Ozono en Pacientes de Terapia Intensiva del Hospital ‘Carlos J. Finlay,’” Revista CENIC Ciencias Biologicas 20, no. 1-2-3 (1989): 128–35.
9. M. Bette et al., “Efficiency of Tazobactam/Piperacillan in Lethal Peritonitis Is Enhanced after Preconditioning of Rats with O3/ O2-Pneumoperitoneum,” Shock 25, no. 1 (January 2006): 23–29.
10. R. A. Mayer, “Experiences of a Pediatrician Using Ozone as a Chemotherapeutic Agent for the Treatment of Diseases of Children,” in Medical Applications of Ozone, ed. Julius LaRaus (Norwalk, Conn.: International Ozone Association, Pan American Committee, 1983), 205.
11. S. N. Gorbunov et al., “The Use of Ozone in the Treatment of Children Suffered Due to Different Catastrophies,” in Ozone in Medicine, vol. 3 of Proceedings of the 11th Ozone World Congress (Stamford, Conn.: International Ozone Association, Pan American Committee, 1993), M-3-31-33.
12. G. A. Balla et al., “Use of Intra-arterial Hydrogen Peroxide to Promote Wound Healing,” American Journal of Surgery 108 (November 1964).
13. A. A. Daulbaeva and G. T. Baizakova, “[Effect of Ozone on Antibiotic Sensitivity of Microorganisms],” Stomatologiia 82, no. 2 (2003): 36–38. [In Russian.]
14. J. Wainstein et al.,“Efficacy of Ozone-Oxygen Therapy for the Treatment of Diabetic Foot Ulcers,” Diabetes Technology & Therapeutics 13, no. 12 (December 2011): 1255–60.
15. World Health Organization, “Buruli Ulcer Fact Sheet,” updated February 2016, www.who.int/mediacentre/factsheets/fs199/en (accessed September 15, 2016).
16. A. Bertolotti et al., “The Use of Ozone Therapy in Buruli Ulcer Had an Excellent Outcome,” BMJ Case Reports (2013), doi:10.1136/bcr-2012 -008249 (accessed September 15, 2016).
17. A. Thabusum et al., “Ozone: The New Nemesis of Canker Sore,” Journal of Clinical and Diagnostic Research 9, no. 3 (March 2015): ZC01–4.
CHAPTER 24. ATHLETIC PERFORMANCE, PREVENTIVE HEALTH, AND HEALTHY AGING
1. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 341.
2. M. Nabil Mawsouf, Ozone in Athletes, presentation at the First International Congress of Ozone in Medicine, Cairo, 2006.
3. Terry O’Hanlon, “Queen Mum Is Staying Young with Ozone Jabs,” Sunday Mirror (May 13, 2001).
4. ShadiaBarakat, Role of Medical Ozone in Angiogenesis: To Promote Healthy Aging, presentation at the First International Congress of Ozone in Medicine, Cairo, 2006.
CHAPTER 25. DENTISTRY
1. RenateViebahn-Haensler, Ozone in Medicine (Iffezheim, Germany: ODREI-Publishers, 2002), 24.
2. M. V. Marshall et al., “Hydrogen Peroxide: A Review of Its Use in Dentistry,” Journal of Periodontology 66, no. 9 (September 1995): 786–96.
3. Fritz Kramer, “Ozone in Dental Practice,” in Medical Applications of Ozone, ed. Julius LaRaus (Norwalk, Conn.: International Ozone Association, Pan American Committee, 1983), 258–65.
4. C. G. Nogales et al., “Comparison of the Antimicrobial Activity of Three Different Concentrations of Aqueous Ozone on Pseudomonas aeruginosa, Staphylococcus aureus, and Enterococcus faecalis—In Vitro Study,” Revista Española de Ozonoterapia 4, no. 1 (2014): 9–15.
5. G. Gupta and M. Bansal, “Ozone Therapy in Periodontics,” Journal of Medicine and Life 5, no. 1 (January–March 2012): 59–67.
6. J. Wennstrom and J. Lindhe, “Effect of Hydrogen Peroxide on Developing Plaque and Gingivitis in Man,” Journal of Clinical Periodontology 6 (1979): 115–30.
7. M. V. Marshall et al., “Hydrogen Peroxide: A Review of Its Use in Dentistry,” Journal of Periodontology 66, no. 9 (September 1995).
8. G. Klinger et al., “Bacteriological Studies during Conservative Treatment of Periapical Inflammations,” Stomatol-DDR (December 25, 1975): 801–8.
9. S. J. Meraw and C. M. Reeve, “A Case Report: Treating Localized Refractory Idiopathic Gingivitis with Superoxol,” Journal of the American Dental Association 129, no. 4 (April 1998): 470–72.
10. V.S. Agapov et al., “[Ozone Therapy in Treatment of Local Sluggish Suppurative Inflammation of Maxillofacial Soft Tissues],” Stomatologiia 80, no. 3 (2001): 23–27. [In Russian.]
11. H. Hasturk et al., “Efficacy of a Fluoridated Hydrogen Peroxide–Based Mouthrinse for the Treatment of Gingivitis: A Randomized Clinical Trial,” Journal of Periodontology 75, no. 1 (January 2004): 57–65.
12. I. Khatriet al., “Evaluation of Effect of Topical Ozone Therapy on Salivary Candidal Carriage in Oral Candidiasis,” Indian Journal of Dental Research 26, no. 2 (March–April 2015): 158–62.
13. Julian Holmes, “New Technologies for Dental Care,” Dentistry (May 16, 2002): 14.
14. Aylin Baysan and Edward Lynch, “Effect of Ozone on the Oral Microbiota and Clinical Severity of Primary Root Caries,” American Journal of Dentistry 17 (February 2004): 56.
15. Aylin Baysan and Edward Lynch, “The Use of Ozone in Dentistry and Medicine,” Primary Dental Care 12 (April 2005): 51.
16. Julian Holmes, “Clinical Reversal of Root Caries Using Ozone, Double-Blind, Randomised, Controlled 18-Month Trial,” Gerodontology 20 (December 2003): 106–14.
17. Russell Beggs, “Reliable Caries Reversal: Another Paradigm Shift?” Dentistry Today 23 (February 2004): 16.
18. R. Noites et al., “Synergistic Antimicrobial Action of Chlorhexidine and Ozone in Endodontic Treatment,” BioMed Research International, article ID 592423 (2014): 6 pages, doi:10.1155/2014/592423 (accessed September 15, 2016).
19. F. Kaptan et al., “In vitro Assessment of the Recurrent Doses of Topical Gaseous Ozone in the Removal of Enterococcus faecalis Biofilms in Root Canals,” Nigerian Journal of Clinical Practice 17, no. 5 (September–October 2014): 573–78.
20. Philip Mollica and Robert E. Harris Jr., “Integrating Oxygen/Ozone Therapy into Your Practice, www.ozonefordentistry.com/Doc.html (accessed August 10, 2015).
21. H. O. Kazancioglu et al., “Effects of Ozone Therapy on Pain, Swelling, and Trismus Following Third Molar Surgery,” International Journal of Oral and Maxillofacial Surgery 43, no. 5 (May 2014): 644–48.
22. D. F. McKenna, “The Effect of Subgingival Ozone and/or Hydrogen Peroxide on the Development of Peri-implant Mucositis: A Double-Blind Randomized Controlled Trial,” International Journal of Oral & Maxillofacial Implants 28, no. 6 (November–December 2013): 1483–89.
23. Rajiv Saini, “Ozone Therapy in Dentistry: A Strategic Review,” Journal of Natural Science, Biology and Medicine 2, no. 2 (July–December 2011): 151–53.
24. William C. Domb, “Ozone Therapy in Dentistry,” Interventional Neuroradiology 20 (2014): 634.
CHAPTER 26. VETERINARY MEDICINE
1. Margo Roman, “Ozone Therapy in the Veterinary Practice,” IVC Journal, Fall 2013, http://ivcjournal.com/ozone-therapy-in-the-veterinary-practice (accessed September 15, 2016).
2. Kathy Backus and Jonathan Lowe, “Ozone & Biophotonic Therapy,” IVC Journal, Summer 2014, http://ivcjournal.com/ozone-biophotonic-therapy (accessed September 15, 2016).
3. Gerald M. Buchoff, “Alternative Veterinary Pain Control for Surgeries and Injuries,” IVC Journal, Summer 2015, http://ivcjournal.com/alternative-veterinary-pain-control-for-surgeries-and-injuries (accessed September 15, 2016).
4. Robert Smatt, The Use of Ozone and Oxygen Therapies in Veterinary Medicine (San Diego, Calif.: Genesee Bird and Pet Clinic, n.d.).
5. Ibid.
6. Ibid.
7. Interview with Robert Smatt, December 12, 2005.
8. Martin Goldstein, The Nature of Animal Healing (New York: Random House, 1999), 158–59.
9. Ibid., 198.
10. Ibid., 202.
11. Ibid., 230–31.
12. Ibid., 247.
13. Ibid., 274–75.
14. C. T. Liou et al., “Effect of Ozone Treatment in Eimeria colchici Oocysts,” Journal of Parasitology 88 (February 2002): 159–62.
15. N. Terasaki et al., “Changes of Immunological Response after Experimentally Ozonated Autohemnoadministration in Calves,” Journal of Veterinary Medical Sciences 63, no. 12 (2001): 1327–30.
16. K. S. McKenzie et al., “Aflatoxicosis in Turkey Poults Is Prevented by Treatment of Naturally Contaminated Corn with Ozone Generated by Electrolysis,” Poultry Science 77, no. 8 (August 1998): 1094–102.
17. A. Otaga and H. Nagahata, “Intramammary Application of Ozone Therapy to Acute Clinical Mastitis in Dairy Cows,” Journal of Veterinary Medical Sciences 62, no. 7 (2000): 681–86.
18. Velio Bocci, Oxygen-Ozone Therapy: A Critical Evaluation (Dordrecht, Netherlands: Kluwer Academic Publishers, 2002), 338–39.
19. Y. Shinozuka et al., “Comparison of the Amounts of Endotoxin Released from Escherichia coli after Exposure to Antibiotics and Ozone: An In Vitro Evaluation,” Journal of Veterinary Medical Science 70, no. 4 (April 2008): 419–22.
PART 3. A HOLISTIC PROTOCOL
1. Janet F. Quinn, “The Healing Arts in Modern Health Care,” in Spiritual Aspects of the Healing Arts, ed. Dora Kunz (Wheaton, Ill.: Quest Books, 1985), 121.
2. John C. Pittman, Comprehensive HIV/AIDS Protocol (Salisbury, N.C.: Cure AIDS Now, 1993).
CHAPTER 27. BODY CLEANSING
1. Robert Gray, The Colon Health Handbook (Oakland, Calif.: Rockridge Publishing, 1982), 29.
2. Horst Kief, Therapeutic Significance of Intestinal Insufflation of Medical Ozone (Ludwigshafen, Germany: The Kief Clinic, n.d.).
3. Robert Gray, The Colon Health Handbook (Oakland, Calif.: Rockridge Publishing, 1982), 37, 44.
4. Max Gerson, A Cancer Therapy (Bonita, Calif.: Gerson Institute/Pulse, 1990), 216–17.
5. Keep Hope Alive Newsletter (September 27, 1993).
6. Alfred Vogel, The Nature Doctor (New Canaan, Conn.: Keats Publishing, 1991), 482–83.
7. Interview with Juliane Sacher, January 26, 1994.
8. Velio Bocci, Ozone: A New Medical Drug (Dordrecht, Netherlands: Springer, 2005), 58.
CHAPTER 28. AN OXYGENATION DIET
1. David Pimental, Handbook of Pest Management in Agriculture, 2nd ed. (Boca Raton, Fla.: CRC Press, 1990).
2. Nathaniel Altman, Nathaniel Altman’s Total Vegetarian Cooking (New Canaan, Conn.: Keats Publishing, 1980).
3. Sara Shannon,Good Health in a Toxic World: The Complete Guide to Fighting Free Radicals (New York: Warner Books, 1994).
4. Monica H. Carlsen et al., “The Total Antioxidant Content of More Than 3100 Foods, Beverages, Spices, Herbs and Supplements Used Worldwide,” Nutrition Journal 9, no. 3 (2010), doi:10.1186/1475-2891-9-3.
5. The New Four Food Groups (Washington, D.C.: Physicians Committee for Responsible Medicine, 1991).
6. Dietary Guidelines for Americans 2005 (Washington, D.C.: Department of Health and Human Services and the United States Department of Agriculture, 2005), chapter 5.
7. U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans, 8th ed., December 2015, http://health.gov/dietaryguidelines/2015/guidelines (accessed September 15, 2016).
8. C. H. Farr, Workbook on Free Radical Chemistry and Hydrogen Peroxide Metabolism (Oklahoma City, Okla.: International Bio-Oxidative Medicine Foundation, 1993), 46.
9. S. S. Hendler, The Oxygen Breakthrough (New York: Pocket Books, 1989), 150.
10. Letter from Kurt Donsbach, December 30, 1993.
11. S. Pulugurtha, “Foods to Increase Oxygen in the Blood,” www.livestrong.com/article/344130-foods-to-increase-the-oxygen-in-the-blood (accessed November 6, 2015).
12. P. Sexton et al., “Influence of Mediterranean Diet on Asthma Symptoms, Lung Function, and Systemic Inflammation: A Randomized Controlled Trial,” Journal of Asthma 50, no. 1 (2013): 75–81.
13. Mark Konlee and Conrad LeBeau, Immune Restoration Handbook, 6th ed. (West Allis, Wis.: Keep Hope Alive, 2004), 230–31.
14. Ann Wigmore, Overcoming AIDS (Boston: Ann Wigmore Foundation, 1987), 96.
CHAPTER 29. NUTRITIONAL SUPPLEMENTS AND HEALING HERBS
1. John C. Pittman, Comprehensive HIV/AIDS Protocol (Salisbury, N.C.: Cure AIDS Now, 1993).
2. Letter from Velio Bocci, February 1, 2006.
3. M. J. Stampfer et al., “Vitamin E Consumption and the Risk of Coronary Disease in Women,” New England Journal of Medicine 328 (1993): 1444–49.
4. E. J. Jacobs et al., “Vitamin C and Vitamin E Supplement Use and Bladder Cancer Mortality in a Large Cohort of U.S. Men and Women,” American Journal of Epidemiology 156 (2002): 1002–10.
5. T. Tankova et al., “Treatment for Diabetic Mononeuropathy with alpha-Lipoic Acid,” International Journal of Clinical Practice 59, no. 6 (June 2005): 645.
6. G. Zimmer et al., “Dose/Response Curves of Lipoic Acid R- and S-Forms in the Working Rat Heart during Reoxygenation: Superiority of the R-Entantiomer in the Enhancement of Aortic Flow,” Journal of Molecular and Cellular Cardiology 27 (1995): 1895–903.
7. S. Sola et al., “Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic Syndrome: Results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) Study,” Circulation 111 (January 25, 2005): 343–48.
8. Parris M. Kidd, “Glutathione: Systemic Protection against Oxidative and Free Radical Damage,” Alternative Medicine Review 2 (1997): 153–76.
9. International Scientific Committee of Ozone Therapy, Madrid Declaration on Ozone Therapy, 2nd ed. (Madrid: International Scientific Committee of Ozone Therapy, 2015): 15.
10. Z. L. Zhou et al., “[Study on Effect of Astragalus Injection in Treating Congestive Heart Failure],” Zhongguo Zhing Xi Yi Jie He Za Zhi 21 (October 2001): 747–49. [In Chinese.]
11. J. Dong et al., “[Effects of Large Dose of Astragalus membranaceus on the Dendritic Cell Induction of Peripheral Mononuclear Cell and Antigen Presenting Ability of Dendritic Cells in Children with Acute Leukemia],” Zhongguo Zhing Xi Yi Jie He Za Zhi 25 (October 2005): 872–75. [In Chinese.]
12. L. L. Agnew et al., “Echinacea Intake Induces an Immune Response through Altered Expression of Leucocyte hsp70, Increased White Cell Counts and Improved Erythrocyte Antioxidant Defences,” Journal of Clinical Pharmacy & Therapeutics 30 (August 2005): 363.
13. T. Heinenn-Kammerer et al., “[Effectiveness of Echinacea in Therapy of Chronic Recurrent Respiratory Disease],” Gesundheitswesen 67 (April 2005): 296–301. [In German.]
14. V. Goel et al., “Efficacy of a Standardized Echinacea Preparation (Echinilin™) for the Treatment of the Common Cold: A Randomized, Double-Blind, Placebo-Controlled Trial,” Journal of Clinical Pharmacy & Therapeutics 29 (February 2004): 75.
15. Ellen Tattleman, “Health Effects of Garlic,” American Family Physician 72 (July 2005): 103–6.
16. H. S. Chung et al., “Ginkgo biloba Extract Increases Ocular Blood Flow Velocity,” Journal of Ocular Pharmacology and Therapeutics 15 (June 1999): 233–40.
17. M. R. Lyon et al., “Effect of the Herbal Extract Combination Panax quinquefolium and Ginkgo biloba on Attention-Deficit Hyperactivity Disorder: A Pilot Study,” Journal of Psychiatry & Neuroscience 26 (May 2001): 221–28.
18. P. L. LeBars et al., “Influence of the Severity of Cognitive Impairment on the Effect of the Ginkgo biloba Extract EGb 761 in Alzheimer’s Disease,” Neuropsychobiology 45 (2002): 19–26.
19. D. L. McKay and Jeffrey B. Blumberg,“The Role of Tea in Human Health: An Update,” Journal of the American College of Nutrition 21, no. 1 (2002): 1–12.
20. T. Nagao et al., “Ingestion of a Tea Rich in Catechins Leads to a Reduction in Body Fat and Malondialdehyde-Modified LDL in Men,” American Journal of Clinical Nutrition 81, no. 1 (January 2005): 122–29.
21. H. J. Woo and Y. H. Choi, “Growth Inhibition of A549 Human Lung Carcinoma Cells by Beta-Lapachone through Induction of Apoptosis and Inhibition of Telomerase Activity,” International Journal of Oncology 26 (April 2005): 1017–23.
22. J. H. Lee et al., “Down-Regulation of Cyclooxygenase-2 and Telomerase Activity by Beta-Lapachone in Human Prostate Carcinoma Cells,” Pharmacological Research 51 (June 2005): 553–60.
CHAPTER 30. EXERCISE AND BREATHING: OXYGENATION AND OXIDATION
1. Physical Activity and Health: A Report of the Surgeon General (Atlanta, Ga.: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1999).
2. G. W. Davison et al., “Manipulation of Systemic Oxygen Flux by Acute Exercise and Normobaric Hypoxia: Implications for Reactive Oxygen Species Generation,” Clinical Science (London) 111, no. 1 (January 2006): 133–41.
3. P. G. Peters et al., “Short-Term Isometric Exercise Reduces Systolic Blood Pressure in Hypertensive Adults: Possible Role of Reactive Oxygen Species (R1),” International Journal of Cardiology (October 17, 2005).
4. N. B. Vollaard et al., “Exercise-Induced Oxidative Stress: Myths, Realities and Physiological Relevance,” Sports Medicine 35, no. 12 (2005): 1045–62.
5. Physical Activity and Health: A Report of the Surgeon General (Atlanta, Ga.: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1999).
6. U. Wisløff et al.,“Superior Cardiovascular Effect of Aerobic Interval Training versus Moderate Continuous Training in Heart Failure Patients,” Circulation 115 (2007): 3086–94.
7. Conor McLean et al., “Effects of Exercise Intensity on Postexercise Endothelial Function and Oxidative Stress,” Oxidative Medicine and Cellular Longevity, article ID 723679 (2015): 8 pages, doi:10.1155/2015/723679.
8. S. S. Hendler, The Oxygen Breakthrough (New York: Pocket Books, 1989), 220.
9. Yogi Ramacharaka, The Science of Breath (Chicago: Yogi Publication Society, 1905), 40–41.
10. Majid Ali, “Your Health: One Way to Breathe,” Easy English News 21 (February 2016): 5.
CHAPTER 31. EMOTIONS, MIND, AND SPIRIT
1. Donald M. Epstein, “There Is No Cure for Healing,” Association for Network Chiropractic Newsletter (Summer 1993): 1.
2. Larry Dossey, Space, Time & Medicine (Boulder, Colo.: Shambhala Publications, 1982), 183.
3. Sara Shannon, Good Health in a Toxic World: The Complete Guide to Fighting Free Radicals (New York: Warner Books, 1994).
4. T. Dethlefsen and R. Dahlke, The Healing Power of Illness (Rockport, Mass.: Element Books, 1990), 7.
5. O. Carl Simonton, Stephanie Matthews-Simonton, and James L. Creighton, Getting Well Again (New York: Bantam Books, 1980), 61–62.
6. Jason Serenus, ed., Psychoimmunity and the Healing Process (Berkeley, Calif.: Celestial Arts, 1986), 72.
7. C. Mikluscak-Cooper and E. E. Miller, Living in Hope (Berkeley, Calif.: Celestial Arts, 1990), 250.
8. Scott J. Gregory, A Holistic Protocol for the Immune System (Joshua Tree, Calif.: Tree of Life Publications, 1989), 83–84.
9. Candace B. Pert, Molecules of Emotion (New York: Scribner, 1997), 192–93.
10. Norman Cousins,Anatomy of an Illness (New York: W. W. Norton, 1979).
11. Karen Shultz, “Laughter and Smiling: Good Medicine,” in The Essence of Healing (Tucson, Ariz.: Theosophical Order of Service, 1984), 62.
12. Diane Chun, “Experts Dismiss Scare over Bird Flu,” Gainesville [Fla.] Sun (November 3, 2005).
13. Donald M. Epstein, Healing Myths, Healing Magic (San Rafael, Calif.: Amber-Allen Publishing, 2000), 12–13.
14. Louise L. Hay, The AIDS Book (Santa Monica, Calif.: Hay House, 1988), 132.
15. Swami Sivananda Radha, The Divine Light Invocation (Portholl, Idaho: Timeless Books, 1966).
CONCLUSION. THE FUTURE OF OXYGEN THERAPIES
1. “Pharmaceuticals/Health Products, Industry Profile: Summary 2015,” www.opensecrets.org/lobby/indusclient.php?id=h04 (accessed February 24, 2016).
2. Zdenek Rasplicka, website citation, OzoneLab Instruments, www.ozoneservices.com (accessed January 2006).
3. Ibid.
APPENDIX 1. OXYGEN PRODUCTS, SERVICES, AND APPLICATIONS
1. “The AAO Position on DIV (Direct I.V. Injection of Ozone/Oxygen),” http://aaot.us/?page=PostitionPapers (accessed December 24, 2015); American Academy of Ozonotherapy, AAO Guidelines for Medical, Dental, “UltraPure” Laboratory Research Ozone Generators, 3rd ed. (n.p.: American Academy of Ozonotherapy, 2013), 1–7.
2. Letters from Zdenek Rasplicka of Ozone Services, September 1997.
3. U.S. Environmental Protection Agency, 2015 National Ambient Air Quality Standards (NAAQS) for Ozone, www.epa.gov/ozone-pollution/2015-national-ambient-air-quality-standards-naaqs-ozone (accessed March 21, 2017).
4. U.S. Food and Drug Administration, Code of Federal Regulations, Title 21, Volume 8 (Medical Devices). April 1, 2016, www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=801.415 (accessed March 21, 2017).
5. Bradford Cook, “Ozone Treatment Gains Popularity,” New Hampshire Business Review 18 (May 24, 1996): 19.
6. Letters from Zdenek Rasplicka of Ozone Services, September 1997.
7. Anthony DePalma, “Just When You Thought Air Was Free,” New York Times (June 12, 1997): 27, 30.
8. Press release for Oxygen Station, September 1997.